ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,501Medicare Part D Prescriptions Filled, Including Refills

Rank: 14 out of 36

$505K Total Retail Price of All Prescriptions

Rank: 17 out of 36

496 Patients Receiving at Least One Drug in Part D
93%Patients 65 Years and Older
27% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Georgia
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

2% of this provider’s 496 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

1% of this provider’s 10,057 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$48 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 25.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Georgia
SIMVASTATIN 565 559 1 2
LEVOTHYROXINE SODIUM 407 385 2 4
AMLODIPINE BESYLATE 328 323 3 1
TRAMADOL HCL 292 281 4 14
FUROSEMIDE 271 263 5 5
POTASSIUM CHLORIDE 247 228 6 15
OMEPRAZOLE 229 214 7 6
METOPROLOL SUCCINATE 228 218 8 18
METOPROLOL TARTRATE 227 219 9 8
KLOR-CON M20 218 218 10 32
METFORMIN HCL 216 214 11 11
LISINOPRIL 207 204 12 3
ZOLPIDEM TARTRATE 205 204 13 24
WARFARIN SODIUM 170 170 14 17
PRAVASTATIN SODIUM 170 158 14 21
LOSARTAN POTASSIUM 169 169 16 23
HYDROCHLOROTHIAZIDE 167 156 17 9
MELOXICAM 164 157 18 53
ATORVASTATIN CALCIUM 160 151 19 22
ISOSORBIDE MONONITRATE ER 144 144 20 42
CLOPIDOGREL 126 121 21 33
AZITHROMYCIN 122 112 22 51
LOSARTAN-HYDROCHLOROTHIAZIDE 115 110 23 63
CITALOPRAM HBR 108 107 24 16
PLAVIX 99 95 25 52
ZOSTAVAX 99 96 25 164
ALENDRONATE SODIUM 98 98 27 34
LANTUS 97 88 28 38
ALLOPURINOL 96 94 29 44
GABAPENTIN 94 88 30 10
RAMIPRIL 92 92 31 96
FLUTICASONE PROPIONATE 85 79 32 45
CLONIDINE HCL 85 75 32 50
LISINOPRIL-HYDROCHLOROTHIAZIDE 83 80 34 49
DIGOXIN 79 79 35 61
AMLODIPINE BESYLATE-BENAZEPRIL 78 76 36 94
INSULIN SYRINGE 75 70 37 72
PANTOPRAZOLE SODIUM 73 62 38 35
OXYBUTYNIN CHLORIDE 70 70 39 96
GLIMEPIRIDE 68 67 40 46
NEXIUM 66 32 41 26
JANUVIA 64 56 42 55
CIPROFLOXACIN HCL 60 56 43 60
CARVEDILOL 59 57 44 20
MONTELUKAST SODIUM 59 52 44 192
GLYBURIDE 58 53 R 46 158
DONEPEZIL HCL 58 58 46 12
BENICAR HCT 56 45 48 197
SINGULAIR 56 50 48 101
SYNTHROID 56 56 48 68
ATENOLOL 56 52 48 27
SPIRONOLACTONE 55 55 52 90
BISOPROLOL-HYDROCHLOROTHIAZIDE 55 53 52 199
LANTUS SOLOSTAR 53 39 54 130
NIFEDIPINE ER 53 53 54 104
LANSOPRAZOLE 51 51 56 214
CRESTOR 51 51 56 36
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 18, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.